What is GILERO?
Gilero operates as a comprehensive service provider, offering end-to-end solutions in design, development, and contract manufacturing. The company specializes in the intricate medical device and drug delivery/combination product markets. Leveraging extensive industry experience and a robust in-house engineering team, Gilero is adept at producing a wide array of products, from simple consumable medical devices to sophisticated electromechanical drug delivery systems. Its expanding global presence highlights its capacity to serve a diverse and demanding clientele.
How much funding has GILERO raised?
GILERO has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for GILERO?
The substantial late-stage funding positions GILERO for significant strategic advancements. This capital infusion is likely to fuel further expansion of its manufacturing capabilities, enhance its research and development initiatives, and potentially broaden its market reach through strategic partnerships or acquisitions. The company's focus on complex medical devices and drug delivery systems suggests a trajectory aimed at capturing larger contracts and solidifying its role as a key player in the healthcare supply chain. Continued investment in innovation and operational scaling will be critical for sustained success.
See full GILERO company page
